CD8A and neoplasm: Indeed, after internalization of the BCR/antigen complex, the tumor antigens presented on MCH-II complex or eventually MCH-I complex by cross-presentation respectively activate CD4+ or CD8+ T cells that are specific of the presented antigens (Figure 1).